Skip to main content

Fibromyalgia/Pain

We are three weeks out from RheumNow Live. Are you planning on attending? https://t.co/vJlU0Z3Q3x

Dr. John Cush @RheumNow( View Tweet )

Feb 26, 2021

RheumNow Podcast – Sweet Lies or Hard Truths? (2.26.2021)

Feb 26, 2021

Dr. Jack Cush reviews and discusses the news and Journal reports from the past week on RheumNow.com.

Read Article

Diagnosis & Treatment of Osteoarthritis Reviewed

Feb 22, 2021

Katz, Arant and Loeser have published a comprehensive open-read overview of osteoarthritis (OA) of the hip and knee in JAMA; underscoring the impact, advances, disappointments and guidelines put forth. 



OA affects an estimated more than 240 million people worldwide, and more

Read Article
Abrupt Cessation of Long-Term Opioid Prescribing Common Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed. https://t.co/bCnaJHECd0 https://t.co/PfM9BCNPyC
Dr. John Cush @RheumNow( View Tweet )
Feb 09, 2021
Abrupt Cessation of Long-Term Opioid Prescribing Common Medicare beneficiaries were increasingly likely to have long-term opioid therapy stopped in recent years and medication changes often were abrupt, not tapered, an observational study showed. https://t.co/bCnaJHECd0 https://t.co/ermkbK6LMN
Dr. John Cush @RheumNow( View Tweet )
Feb 06, 2021
Consults in Cars--have telehealth consults gone too far? https://t.co/INbKZ3xxty https://t.co/X2RwktCd2U
Dr. John Cush @RheumNow( View Tweet )
Feb 03, 2021
Download available--Maintaining a Healthy Immune System https://t.co/wiWzZldnik https://t.co/ZL3r3dHPC2
Dr. John Cush @RheumNow( View Tweet )
Feb 01, 2021
British registry 801 axial SpA pts; 646 did not hve fibromyalgia at baseline & 46 (7%) developed FM over time. Of 115 axSpa w/ baseline FM, 77 (2/3) recovered. FM more likely with high Dz activity ((OR 1.27) & widespread pain (OR 1.14) https://t.co/4jOdaXIJuB https://t.co/ruOYj5HmMX
Dr. John Cush @RheumNow( View Tweet )
Feb 01, 2021
Rheums: Got a Rheumatology question or case for RheumNow? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/wzNmOzH4VE https://t.co/6w8CAAUkO6
Dr. John Cush @RheumNow( View Tweet )
Jan 26, 2021
Sign up to attend RheumNow Live--March 20 and 21. CME credits available https://t.co/vJlU0Z3Q3x https://t.co/Z0ectgFD2d
Dr. John Cush @RheumNow( View Tweet )
Jan 20, 2021
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE
Dr. John Cush @RheumNow( View Tweet )
Jan 16, 2021
Download your RheumaKnowledgy Card https://t.co/L7O0UFjEBV https://t.co/iFtVKERnjC
Dr. John Cush @RheumNow( View Tweet )
Jan 12, 2021
Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/NDhYNX50e2

Dr. John Cush @RheumNow( View Tweet )

Jan 09, 2021

EULAR Guidance on Patient Adherence to Meds

Jan 06, 2021

Non-adherence may be the single most untold risk to suboptimal outcomes in the care of musculoskeletal disease.  It has been estimated that 30-80% of patients with rheumatic and musculoskeletal diseases (RMDs) are nonadherent to prescribed regimens.  EULAR has commissioned a task force to

Read Article
Join us this March for RheumNow Live! Sign up via the link below. https://t.co/vJlU0Z3Q3x https://t.co/G1s3F7zKlI
Dr. John Cush @RheumNow( View Tweet )
Jan 05, 2021

Best of 2020: The COVID-19 Global Rheumatology Registry

Dec 24, 2020

What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease

Read Article
Phase II/III, double-blind, RCT shown fasinumab (nerve growth factor inhibitor) at higher doses (9mg q4 or q8wks), but not lower doses, improved chronic low back pain w/ best responses at wk 16.. Rapid OA progression seen more w/ FAS (3.8%) vs PBO (0.7%) https://t.co/OfdEsAZuDe

Dr. John Cush @RheumNow( View Tweet )

Dec 09, 2020
Fibromyalgia Therapies Show Limited Evidence of Pain and QOL Reduction https://t.co/jpZC4KFygJ https://t.co/k7WFNQg9AY
Dr. John Cush @RheumNow( View Tweet )
Nov 30, 2020
The presence of fibromyalgia in psoriatic arthritis correlates with the clinical outcome scores. Ultrasound evaluation can be useful to evaluate disease activity in the presence of fibromyalgia @rheumnow #ACR20 Abstr#315 #ACRbest

Dr. Antoni Chan @synovialjoints( View Tweet )

Nov 06, 2020
Early RA pts may develop chronic widespread pain. Not all have fibromyalgia. Multiple areas of pain & inflammation ^ chronic pain & other factors ie women high initial pain longer symptoms @CRASCRRheum @RheumNow #ACR20 abstr#187 1/3 at onset have regional pain 1/4 at 1yr https://t.co/7qOxH4h7Dd https://t.co/IFO1uwyR0o
Janet Pope @Janetbirdope( View Tweet )
Nov 06, 2020

Fibromyalgia Therapies Show Limited Evidence of Pain and QOL Reduction

Oct 27, 2020

JAMA Internal Medicine has published a review showing that most currently approved therapies for fibromyalgia (FM) do not have high-quality evidence to support their use; with some reducing pain or improving quality of life (QOL) in the short term, but overall effect size is not impressive.

Read Article

IL-1 Inhibition Alters Arthroplasty Rates

Oct 07, 2020

A subanalysis of the CANTOS trial suggests that inhibition of interleukin-1β (IL-1β) can reduce rates of incident hip or knee replacement (THR/TKR) surgeries.

Read Article

RheumNow Podcast – Function Follows Form (10.2.20)

Oct 01, 2020

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Regulatory approvals, update on global rheumatology alliance, smoking and psoriasis, gabapentin let down and defining difficult RA.

Read Article

Gabapentin Fails to Lessen Chronic Pelvic Pain

Sep 27, 2020

Lancet reports that in a randomized, blinded, controlled trial, gabapentin failed to significantly lower pain scores in women with chronic pelvic pain, and was associated with higher adverse event rates compared to placebo.

Read Article
Global task force establishes protocols for medical cannabis use to treat pain. Start low (5mg CBD) and titrate up (max 40 mg) - ALL Expert opinion, no good evidence (largely bunk?) https://t.co/HyYU0tGVF5

Dr. John Cush @RheumNow( View Tweet )

Sep 23, 2020
×